| Table 4: | |
|
Relative
Risks of a First VTE in
Selected Hypercoagulable States |
|
| Hypercoagulable State | Relative
Risk of Lifetime Single VTE |
| Factor V Leiden | 2-10 |
| Prothrombin G20210A | 2-6 |
| Factor
V Leiden and prothrombin G20210A ("double-heterozygous") |
20.0 |
| Protein C deficiency | 6.5-31* |
| Protein S deficiency | 2-36* |
| Antithrombin deficiency | 5-40* |
| Hyperhomocysteinemia | 2-4 |
| Lupus anticoagulant | 11 |
| Anticardiolipin antibodies | 3.2 |
| * Relative risks are highly variable, depending on whether they were derived from population- or family-based studies. Differences in risk can be explained in part by greater difficulty in obtaining reliable population-based estimates due to the overall low prevalence of these disorders. It is also possible that event rates were overestimated in early familial studies. | |
|
Copyright
2003 The Cleveland Clinic Foundation
|
Return to Hypercoagulable States Chapter